ArticleFrontiers in medicine2026

Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system.

Pan Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.